Glycyrrhetinic acid derivatives for treating hyperkalemia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11768319
APP PUB NO 20210163524A1
SERIAL NO

16636596

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a compound of formula (I) or a salt thereof: (I) wherein X, L, V, R1, R2, R3 and R4, are as defined herein. These compounds are inhibitors of 11-hydroxysteroid dehydrogenase type 2 (11-HSD-2) and are used to treat hyperkalemia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ARDELYX, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Tao Fremont, US 1089 14323
Dragoli, Dean Fremont, US 19 31
Leadbetter, Michael Fremont, US 11 22
Lewis, Jason Fremont, US 76 920
Luehr, Gary Fremont, US 13 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 26, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 26, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 26, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00